Today: 10 June 2026
Lam Research earnings beat lifts LRCX after hours as forecast tops estimates
28 January 2026
1 min read

Lam Research earnings beat lifts LRCX after hours as forecast tops estimates

SAN FRANCISCO, Jan 28, 2026, 14:15 PST

  • Shares climbed in after-hours trading following Lam’s fiscal Q2 results, which beat expectations
  • The chip-tool maker projected March-quarter revenue around $5.7 billion
  • The company reported that China made up 35% of its quarterly revenue

Lam Research shares climbed roughly 2% in early after-hours on Wednesday after the chip equipment maker posted fiscal Q2 results that exceeded forecasts. The uptick came soon after the earnings announcement, according to Seeking Alpha.

The results come as investors seek confirmation that chipmakers continue to invest in new factory equipment despite a volatile economy and stricter trade regulations. Lam occupies a central position in this cycle, providing tools essential for producing cutting-edge logic and memory chips powering AI servers and premium devices.

The key now is that equipment demand often comes in waves. When major chipmakers slash or boost capital spending, suppliers like Lam see an immediate impact — and the same goes for peers like Applied Materials, ASML, and Tokyo Electron.

Lam reported a roughly 22% jump in revenue for the quarter ending Dec. 28, hitting $5.34 billion. Adjusted (non-GAAP) earnings came in at $1.27 per share, while the adjusted gross margin stood at 49.7%, reflecting profit after direct costs. The company projects March-quarter revenue around $5.70 billion, with a $300 million margin of error, and adjusted EPS near $1.35, give or take 10 cents. Gross margin is expected to hover around 49%. CEO Tim Archer said, “Lam delivered another strong quarter to cap a record year.” China accounted for 35% of the quarterly revenue, and sales tied to customer support — including service, spares, and upgrades — reached $1.99 billion. PR Newswire

FactSet estimates shared by MT Newswires have the Street expecting $1.17 per share on $5.23 billion in revenue before the report drops. Lam’s stock last changed hands at $248.62 in after-hours trading, up from a close of $239.58 during the regular session.

Investor’s Business Daily reported the stock reached an all-time high of $243.99 earlier Wednesday, prior to the earnings release.

A note from Zacks Equity Research earlier named Lam its “Bull of the Day,” while calling generator maker Generac its “Bear of the Day.” Kevin Cook, senior stock strategist at Zacks, said the bull case for wafer-fab equipment — the machines that produce chips — has evolved. It’s no longer just about a cyclical rebound; it’s now a structural “content gain” story as devices become more complex. TradingView

Orders could slump fast if customers postpone factory expansions or clear out surplus capacity. Over a third of Lam’s quarterly revenue comes from China, so any stricter U.S. export controls on chipmaking equipment would pose an immediate threat.

Stock Market Today

  • Palantir Technologies (PLTR) Shares Seen Fairly Valued Amid Recent Decline
    June 10, 2026, 5:48 PM EDT. Palantir Technologies has seen its share price fall 13.2% over the past week and 21.3% year to date, following extraordinary gains in prior years. At $132.07 per share, Palantir trades slightly below its estimated intrinsic value of $145.11 based on a Discounted Cash Flow (DCF) analysis, suggesting a modest 9% discount. The company posted $2.69 billion in free cash flow over the past twelve months, with projections rising to $16.11 billion by 2030. Despite recent volatility tied to sentiment on artificial intelligence and software spending, Palantir remains fairly valued but not a clear bargain. Investors should monitor further market developments and valuation metrics to gauge future opportunities or risks.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Gold price today: Bullion pushes toward $5,400 as Fed decision fails to cool the rally
Previous Story

Gold price today: Bullion pushes toward $5,400 as Fed decision fails to cool the rally

AMD stock price: After-hours uptick as AI-chip rally rolls on ahead of Feb. 3 earnings
Next Story

AMD stock price: After-hours uptick as AI-chip rally rolls on ahead of Feb. 3 earnings

Go toTop